Andrew Y Ashikari
Overview
Explore the profile of Andrew Y Ashikari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pellicane J, Beitsch P, Rock D, Budway R, Dul C, Kelemen P, et al.
Surg Oncol
. 2022 Nov;
45:101885.
PMID: 36436423
Background: As more patients with early-stage breast cancer receive neoadjuvant endocrine therapy (NET), there is a need for reliable biomarkers that can identify patients with HR+ HER2- tumors who are...
2.
Whitworth P, Beitsch P, Murray M, Richards P, Mislowsky A, Dul C, et al.
JCO Precis Oncol
. 2022 Sep;
6:e2200197.
PMID: 36108259
Purpose: The prospective Neoadjuvant Breast Registry Symphony Trial compared the 80-gene molecular subtyping signature with clinical assessment by immunohistochemistry and/or fluorescence in situ hybridization in predicting pathologic complete response (pCR)...
3.
Whitworth P, Beitsch P, Pellicane J, Baron P, Lee L, Dul C, et al.
JCO Precis Oncol
. 2022 Apr;
6:e2100463.
PMID: 35476550
Purpose: The 80-gene molecular subtyping signature (80-GS) reclassifies a proportion of immunohistochemistry (IHC)-defined luminal breast cancers (estrogen receptor-positive [ER+], human epidermal growth factor receptor 2-negative [HER2-]) as Basal-Type. We report...
4.
Whitworth P, Beitsch P, Pellicane J, Baron P, Lee L, Dul C, et al.
Ann Surg Oncol
. 2022 Apr;
PMID: 35378634
Background: The Neoadjuvant Breast Symphony Trial (NBRST) demonstrated the 70-gene risk of distant recurrence signature, MammaPrint, and the 80-gene molecular subtyping signature, BluePrint, precisely determined preoperative pathological complete response (pCR)...
5.
Wood K, Zoghbi Y, Margulies I, Ashikari A, Jacobs J, Salzberg C
Ann Plast Surg
. 2020 Jun;
85(S1 Suppl 1):S109-S113.
PMID: 32539287
Background: In selecting breast implants for breast reconstruction, current preoperative planning largely relies on 2-dimensional measurements, which are often limited in suboptimal accuracy and objectivity. Although the introduction of 3-dimensional...
6.
Wood K, Margulies I, Shay P, Ashikari A, Salzberg C
Plast Reconstr Surg Glob Open
. 2020 Jun;
8(3):e2690.
PMID: 32537347
Methods: Retrospective review of direct-to-implant breast reconstruction patients operated on by a single surgeon (CAS) from 2011 to 2018 was conducted. Patient and operative characteristics, including ADM type, were recorded....
7.
Ashikari A, Kelemen P, Tastan B, Salzberg C, Ashikari R
Gland Surg
. 2018 Jul;
7(3):273-287.
PMID: 29998077
Nipple sparing mastectomy (NSM) has quickly become an accepted technique for patients with selected cancers and for risk reducing surgery. Much of its surgical acceptance over the last decade has...
8.
Salzberg C, Ashikari A, Berry C, Hunsicker L
Plast Reconstr Surg
. 2016 Apr;
138(2):329-337.
PMID: 27064232
Background: Use of acellular dermal matrix for implant-based breast reconstruction appears to be associated with a lower incidence of capsular contracture compared with standard reconstruction. The majority of acellular dermal...
9.
Hunsicker L, Ashikari A, Berry C, Koch R, Salzberg C
Ann Plast Surg
. 2016 Feb;
78(1):35-40.
PMID: 26849284
Background: Although direct-to-implant breast reconstruction is a more concise procedure than 2-stage expander/implant reconstruction, it is less frequently performed. Skeptics of direct-to-implant reconstruction cite risk of postoperative complications as a...
10.
Salzberg C, Ashikari A, Koch R, Chabner-Thompson E
Plast Reconstr Surg
. 2011 Feb;
127(2):514-524.
PMID: 21285756
Background: The advent of skin- and nipple-sparing mastectomy in conjunction with the use of human acellular dermal matrix to provide lower pole coverage has made direct-to-implant immediate breast reconstruction following...